|
Volumn 29, Issue 12, 2007, Pages 943-945
|
Gefitinib in the treatment of advanced non-small cell lung cancer with brain metastasis
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
GEFITINIB;
QUINAZOLINE DERIVATIVE;
AGED;
ARTICLE;
BRAIN TUMOR;
CANCER STAGING;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DIARRHEA;
DISEASE FREE SURVIVAL;
DRUG ANTAGONISM;
FEMALE;
FOLLOW UP;
HUMAN;
KAPLAN MEIER METHOD;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
METASTASIS;
MIDDLE AGED;
PATHOLOGY;
PROPORTIONAL HAZARDS MODEL;
RASH;
SURVIVAL RATE;
AGED;
ANTINEOPLASTIC AGENTS;
BRAIN NEOPLASMS;
CARCINOMA, NON-SMALL-CELL LUNG;
DIARRHEA;
DISEASE-FREE SURVIVAL;
EXANTHEMA;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
KAPLAN-MEIERS ESTIMATE;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PROPORTIONAL HAZARDS MODELS;
QUINAZOLINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
SURVIVAL RATE;
|
EID: 77951630948
PISSN: 02533766
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (0)
|